Drugs / Oxybenzone
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | SHADE UVAGUARD | — | 1992-12-07 | fda.gov ↗ |
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT03582215 | Jul 2018 → Feb 2019 | skin sensitivity to sun | Food and Drug Administration (FDA) | Completed | No outcome recorded |
| Phase 1 | NCT02668536 | Jul → Aug 2017 | melanoma, radiation-induced disorder | Yale University | Completed | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| — | NCT05124899 Comparator | Nov → Dec 2021 | — | HALEON | Completed | No outcome recorded |
| — | NCT05109104 Comparator | Nov → Dec 2021 | — | HALEON | Completed | No outcome recorded |
| — | NCT05085327 Comparator | Oct → Nov 2021 | — | HALEON | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oxybenzone | “Areas will be treated with a standard preparation, consisting of padimate O (7%) and oxybenzone (3%) will be used as the control sunscreen.” NCT02668536 ↗4“SPF Standard (7 percent \[%\] Padimate-O and 3% Oxybenzone)” NCT05109104 ↗ “SPF Standard (7 percent [%] Padimate-O and 3% Oxybenzone)” NCT05124899 ↗ “Ingredients: 3% Avobenzone; 4% Oxybenzone; 6% Octocrylene” NCT03582215 ↗ “Padimate-O and 3% Oxybenzone” NCT05085327 ↗ |
| Route | Topical | “Single topical application” NCT05085327 ↗ |